المؤلفون: Jugnu Jain, Deepthi Chinta, Umeshnandan B Jayaraman, Neha Pathak, Manpreet Kaur, Soma Chatterjee, Meenakshi Swain, Vijay Anand Reddy

المصدر: Cancer Research, Statistics, and Treatment, Vol 2, Iss 1, Pp 16-20 (2019)

مصطلحات موضوعية: crizotinib, immunohistochemistry, nsclc, ros positivity, targeted therapy, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: http://www.crstonline.com/article.asp?issn=2590-3233;year=2019;volume=2;issue=1;spage=16;epage=20;aulast=Jain; https://doaj.org/toc/2590-3233; https://doaj.org/toc/2590-3225

URL الوصول: https://doaj.org/article/38358a73fd004d828a7fa93026aaa3ff

المؤلفون: Manpreet Kaur, Vijay Anand Reddy, Deepthi Chinta, Meenakshi Swain, Umeshnandan B Jayaraman, Soma Chatterjee, Jugnu Jain, Neha Pathak

المصدر: Cancer Research, Statistics, and Treatment, Vol 2, Iss 1, Pp 16-20 (2019)

مصطلحات موضوعية: Pathology, medicine.medical_specialty, education.field_of_study, crizotinib, Crizotinib, business.industry, Population, Cancer, ros positivity, General Medicine, medicine.disease, targeted therapy, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, lcsh:RC254-282, immunohistochemistry, ROS1, Carcinoma, Medicine, Adenocarcinoma, Germ cell tumors, business, education, Lung cancer, nsclc, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a0f68976c624ef3d0e099503eae6f2f
http://www.crstonline.com/article.asp?issn=2590-3233;year=2019;volume=2;issue=1;spage=16;epage=20;aulast=Jain